Liabilities of Vitro Biopharma, Inc. from 31 Oct 2010 to 31 Oct 2025

Taxonomy & unit
us-gaap: USD
Description
Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.
Summary
Vitro Biopharma, Inc. quarterly Liabilities in USD history and change rate from 31 Oct 2010 to 31 Oct 2025.
  • Vitro Biopharma, Inc. Liabilities for the quarter ending 31 Oct 2025 was $21,262,877, a 49% increase year-over-year.
Source SEC data
View on sec.gov
Liabilities, Quarterly (USD)
Liabilities, YoY Quarterly Change (%)

Vitro Biopharma, Inc. Quarterly Liabilities (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $21,262,877 +$7,037,123 +49% 31 Oct 2025 10-K 13 Feb 2026 2025 FY
Q2 2025 $16,707,634 +$2,578,302 +18% 31 Jul 2025 10-Q 12 Sep 2025 2025 Q3
Q1 2025 $15,640,680 +$989,476 +6.8% 30 Apr 2025 10-Q 20 Jun 2025 2025 Q2
Q4 2024 $14,356,224 +$2,167,924 +18% 31 Jan 2025 10-Q 20 Mar 2025 2025 Q1
Q3 2024 $14,225,754 +$4,791,130 +51% 31 Oct 2024 10-K 13 Feb 2026 2025 FY
Q2 2024 $14,129,332 +$5,406,403 +62% 31 Jul 2024 10-Q 16 Sep 2024 2024 Q3
Q1 2024 $14,651,204 +$7,380,128 +102% 30 Apr 2024 10-Q 31 May 2024 2024 Q2
Q4 2023 $12,188,300 +$5,987,629 +97% 31 Jan 2024 10-Q 14 Mar 2024 2024 Q1
Q3 2023 $9,434,624 +$3,696,402 +64% 31 Oct 2023 10-K 28 Jan 2025 2024 FY
Q2 2023 $8,722,929 31 Jul 2023 10-Q 28 Aug 2023 2023 Q3
Q1 2023 $7,271,076 30 Apr 2023 10-Q 13 Jun 2023 2023 Q2
Q4 2022 $6,200,671 31 Jan 2023 10-Q 14 Mar 2023 2023 Q1
Q3 2022 $5,738,222 31 Oct 2022 10-K 29 Jan 2024 2023 FY
Q3 2015 $2,497,970 +$232,382 +10% 31 Oct 2015 10-K 22 Sep 2016 2015 FY
Q2 2015 $2,439,613 +$234,559 +11% 31 Jul 2015 10-Q 30 Mar 2016 2015 Q3
Q1 2015 $2,389,439 +$208,052 +9.5% 30 Apr 2015 10-Q 22 Jan 2016 2015 Q2
Q4 2014 $2,307,582 +$180,413 +8.5% 31 Jan 2015 10-Q 24 Mar 2015 2015 Q1
Q3 2014 $2,265,588 +$255,935 +13% 31 Oct 2014 10-K 22 Sep 2016 2015 FY
Q2 2014 $2,205,054 31 Jul 2014 10-Q 22 Sep 2014 2014 Q3
Q1 2014 $2,181,387 30 Apr 2014 10-Q 19 Jun 2014 2014 Q2
Q4 2013 $2,127,169 31 Jan 2014 10-Q 17 Mar 2014 2014 Q1
Q3 2013 $2,009,653 31 Oct 2013 10-K 13 Feb 2015 2014 FY
Q3 2011 $1,652,635 -$49,185 -2.9% 31 Oct 2011 10-K/A 16 Feb 2012 2011 FY
Q2 2011 $1,611,242 31 Jul 2011 10-Q/A 12 Oct 2011 2011 Q3
Q3 2010 $1,701,820 31 Oct 2010 10-K/A 16 Feb 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.